Antioxidant effects of Carvedilol and Alluporinol in patients with diabetes type II; A randomized, double-blind placebo-controlled clinical trial

被引:0
|
作者
Larijani, B
Afshari, M
Mojtahedi, A
Astanehi-Asghari, F
Hossein-Nezhad, A
Heshmat, R
Rezaie, A
Zamani, MJ
Mostafalou, S
Abdollahi, M
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A513 / A513
页数:1
相关论文
共 50 条
  • [41] A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
    Alkhalaf, Alaa
    Klooster, Astrid
    van Oeveren, Willem
    Achenbach, Ulrike
    Kleefstra, Nanne
    Slingerland, Robbert J.
    Mijnhout, G. Sophie
    Bilo, Henk J. G.
    Gans, Reinold O. B.
    Navis, Gerjan J.
    Bakker, Stephan J. L.
    DIABETES CARE, 2010, 33 (07) : 1598 - 1601
  • [42] The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial
    Kasiri, Hossein
    Ghazaiean, Mobin
    Rouhani, Nima
    Naderi-behdani, Fahimeh
    Ghazaeian, Monireh
    Ghodssi-Ghassemabadi, Robabeh
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (02) : 124 - 131
  • [43] Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial
    Panahi, Yunes
    Saadat, Alireza
    Beiraghdar, Fatemeh
    Nouzari, Seyyedeh Mehrabeh Hosseini
    Jalalian, Hamid R.
    Sahebkar, Amirhossein
    JOURNAL OF FUNCTIONAL FOODS, 2014, 6 : 615 - 622
  • [44] Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Tougaard, Ninna H.
    Frimodt-Moller, Marie
    Salmenkari, Hanne
    Stougaard, Elisabeth B.
    Zawadzki, Andressa D.
    Mattila, Ismo M.
    Hansen, Tine W.
    Legido-Quigley, Cristina
    Horkko, Sohvi
    Forsblom, Carol
    Groop, Per-Henrik
    Lehto, Markku
    Rossing, Peter
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [45] Pantoprazole Improves Glycemic Control in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Singh, Pawan Kumar
    Hota, Debasish
    Dutta, Pinaki
    Sachdeva, Naresh
    Chakrabarti, Amitava
    Srinivasan, Anand
    Singh, Inderjeet
    Bhansali, Anil
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11): : E2105 - E2108
  • [46] Treatment of patients with undifferentiated arthritis with methotrexate: A double-blind placebo-controlled randomized clinical trial
    van Dongen, H.
    van Aken, J.
    Lard, L. R.
    Ronday, H. K.
    Speyer, I.
    Westedt, M. L.
    Allaart, C. F.
    Breedveld, F. C.
    Huizinga, T. W. J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 16 - 16
  • [47] Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial
    Douek, IF
    Allen, SE
    Ewings, P
    Gale, EAM
    Bingley, PJ
    DIABETIC MEDICINE, 2005, 22 (05) : 634 - 640
  • [48] Effect of Lingliptin and Voglibose on metabolic Profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
    Parthan, Girish
    Bhansali, Shobhit
    Kurpad, Anura, V
    Walia, Rama
    Bhat, Kishor
    Bhansali, Anil
    BMC PHARMACOLOGY & TOXICOLOGY, 2018, 19
  • [49] The effects of wheat germ supplementation on metabolic profile in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
    Mohammadi, Hamed
    Karimifar, Mozhgan
    Heidari, Zahra
    Zare, Maryam
    Amani, Reza
    PHYTOTHERAPY RESEARCH, 2020, 34 (04) : 879 - 885
  • [50] Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
    Girish Parthan
    Shobhit Bhansali
    Anura V. Kurpad
    Rama Walia
    Kishor Bhat
    Anil Bhansali
    BMC Pharmacology and Toxicology, 19